Corporate News
Result of General Meeting
06 December 2022
MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces that at the General Meeting held earlier today, all resolutions were duly passed.
Resolution (all are special resolutions) | Votes for1 | % of shares voted2 | Votes against3 | % of shares voted |
Resolution 1 | 99,254,512 | 99.65% | 350,867 | 0.35% |
Resolution 2 | 99,229,512 | 99.65% | 360,867 | 0.35% |
Resolution 3 | 98,833,632 | 99.23% | 771,747 | 0.77% |
Notes:
1 Any proxy appointments which gave discretion to the Chairman have been included in the "for" total.
2 As a percentage of the aggregate of votes "for" plus votes "against".
3 An abstention is not counted towards the votes cast "for" or "against" a resolution.
For further information contact:
MyHealthChecked PLC | ||
Penny McCormick, Chief Executive Officer | via Walbrook PR | |
SPARK Advisory Partners Limited (NOMAD) | Tel: +44 (0)20 3368 3550 | |
Neil Baldwin | ||
Oberon Capital Ltd (Broker) | Tel: +44 (0)20 3179 5344 | |
Mike Seabrook | ||
Walbrook PR Ltd (Media & IR) | Tel: +44 (0)20 7933 8780 or [email protected] | |
Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654 | |
About MyHealthChecked PLC (www.myhealthcheckedplc.com)
MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.
MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests that have been developed following the acquisition of The Genome Store in November 2020. The tests are available online, and in some cases, for over-the-counter purchase.
The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.